DHR's fourth-quarter sales increase 2.1% year over year, benefiting from the solid performance of its Life Sciences and Biotechnology segments.
Vous n'êtes pas connecté
Organic sales volume growth in ASH's Personal Care, Specialty Additives and Intermediates segments largely offset lower volumes in Life Sciences in Q1.
DHR's fourth-quarter sales increase 2.1% year over year, benefiting from the solid performance of its Life Sciences and Biotechnology segments.
PKG's Q4 results reflect the impacts of higher volume and price/mix in both segments.
Tesla reported lower than expected profits Wednesday but confirmed key 2025 benchmarks, saying it will return to sales volume growth and move forward...
Despite year-over-year sales drop in the key business vertical, strength in key end markets such as defense and aerospace supported QRVO's top-line...
HZO's Q1 results reflect a y/y decline in comps, but its margin profile improves on acquisitions and organic growth, boosting resilience.
KMB's Q4 sales and earnings decline year over year. However, organic sales rise on improved volumes and pricing.
GGG's fourth-quarter 2024 sales decline 3% year over year due to lower demand in the Industrial segment.
HP's revenues in the upcoming quarter are expected to have increased, driven by growth in North America Solutions, Offshore Gulf of Mexico and Other...
NDAQ's fourth-quarter results reflect organic growth, higher revenues across three divisions as well as reduced expenses.
BRO's fourth-quarter results reflect improved organic revenues, driven by higher commission and fees and investment income and expanded EBITDAC...